Kimberly-Clark Corporation
KMBBusiness Overview
ticker: KMB step: 01 generated: 2026-05-12 source: quick-research
Kimberly-Clark Corporation (KMB) — Business Overview
Business Description
Kimberly-Clark is a global consumer products company that manufactures and markets personal care, consumer tissue, and professional hygiene products. Founded in 1872 and headquartered in Irving, Texas, the company holds No. 1 or No. 2 market positions in approximately 70 countries. In 2024, KMB launched its "Powering Care" multi-year transformation strategy, simplifying its portfolio and restructuring around three core segments while targeting meaningful margin expansion and higher-quality organic growth.
Revenue Model
KMB earns revenue from branded consumer product sales through retail channels (mass, drug, grocery, club stores) and professional channels (commercial distributors). The business is characterized by high repeat purchase rates, stable demand regardless of economic conditions, and pricing power from dominant brand positions. In 2025, KMB completed a joint venture with Suzano (Brazilian pulp company), contributing its International Family Care and Professional businesses into a 49%-owned JV — this restructured KMB's revenue base from ~$20B to ~$17B while improving the margin profile of retained operations.
Products & Services
- Personal Care — Huggies diapers, Pull-Ups, GoodNites training pants, Kotex feminine care, Poise/Depend adult incontinence
- Consumer Tissue — Kleenex facial tissue, Scott bath tissue, Cottonelle, Viva paper towels, Andrex (UK)
- Professional — WypAll wipers, Kleenex/Scott commercial tissue; served through Suzano JV post-2025
- International Brands — Intimus, Plenitud, Sweety, Softex (emerging markets personal care)
Customer Base & Go-to-Market
KMB sells primarily through mass retail (Walmart, Target, Costco), drug chains, grocery stores, and e-commerce. Professional products go through distribution. Consumer segments skew toward households with young children (Huggies) and older adults (Poise/Depend). Emerging markets (Latin America, Southeast Asia) are a growth priority, driven by rising middle-class demand for premium personal care products.
Competitive Position
KMB competes directly with Procter & Gamble (Pampers, Charmin, Bounty) in most categories. Despite this heavyweight rivalry, KMB has maintained strong positions through brand loyalty, continuous product innovation, and pricing discipline. The "Powering Care" transformation focuses on winning in premium segments and innovation-led volume gains, moving away from commodity/private-label price battles. The Suzano JV enables KMB to reduce exposure to lower-margin tissue manufacturing while retaining the branded upside.
Key Facts
- Founded: 1872
- Headquarters: Irving, Texas
- Employees: ~40,000 (post-JV)
- Exchange: NYSE
- Sector / Industry: Consumer Staples / Household Products
- Market Cap: ~$40–45B (approximate, 2025–2026)
Financial Snapshot
ticker: KMB step: 04 generated: 2026-05-12 source: quick-research
Kimberly-Clark Corporation (KMB) — Financial Snapshot
Income Statement Summary
| Metric | FY2022 | FY2023 | FY2024 | YoY |
|---|---|---|---|---|
| Revenue | ~$20.2B | ~$20.2B | ~$20.1B | ~0% |
| Gross Margin | ~33% | ~34.4% | ~35.8% | +140bps |
| Operating Margin | ~14% | ~15% | ~16% | |
| Net Income | ~$2.0B | ~$2.6B | ~$2.6B | ~0% |
| EPS (adjusted diluted) | ~$6.00 | $6.57 | $7.30 | +11% |
Note: FY2025 revenue ~$17.2B reflects the Suzano JV contribution of International Family Care and Professional businesses. Adjusted EPS continues double-digit growth in 2025.
Cash Flow & Balance Sheet (FY2024)
| Metric | Value |
|---|---|
| Operating Cash Flow | ~$3.2B |
| Free Cash Flow | $2.51B |
| Cash & Equivalents | ~$0.6B |
| Total Debt | ~$8.0B |
Key Ratios (approximate)
- P/E: ~20–22x (adj.) | EV/EBITDA: ~14x | Dividend Yield: ~4%
- Revenue Growth (FY2024 organic): +3.2% | Gross Margin: ~35.8%
Growth Profile
KMB's revenue growth has been modest in absolute terms due to FX headwinds and divestitures, but organic growth of 3%+ driven by pricing and volume gains is a positive trend. The strategic focus is on margin expansion: KMB targets 40% gross margin and 18–20% operating margin by end of decade (from current ~35.8%/~16%), implying significant earnings power increase without needing volume acceleration. Adjusted EPS has grown double-digits in 2023 and 2024, funded by operational efficiencies, premiumization, and cost savings.
Forward Estimates
- FY2026: Organic sales growth guidance of ~2%+ (deceleration from prior years); continued adjusted EPS double-digit growth; gross margin expansion ongoing
- Margin target: 40% gross margin and 18–20% operating margin by end of decade — each 100bps of gross margin expansion = ~$170M in gross profit on ~$17B base
Deeper Financial Analysis
The fundamental tier adds 9 additional research dimensions for $KMB.